0
Your Cart
Item(s)
Qty
Price

No items in your cart

default image
Micronized Progesterone in Perimenopause
04/14/2026

Izmailov et al. conducted a randomized controlled trial examining the use of transdermal estradiol combined with oral micronized progesterone in women in perimenopause. This overview summarizes the study design, key findings, and what the research may suggest for women navigating hormonal changes in this life stage.

About the study

Izmailov et al. conducted a randomized controlled trial examining outcomes in women in perimenopause — a life stage characterized by shifting hormone levels and a wide range of physical and emotional changes. The study looked at the combination of estradiol and oral micronized progesterone, comparing women who received this combination against a control group, and tracked a range of outcomes over a defined study period.

What the researchers measured

The study tracked vasomotor experiences (including hot flashes and night sweats), sleep quality, psychoemotional wellbeing, and overall quality of life, alongside safety parameters. This broad set of outcomes reflects the varied ways that hormonal fluctuation in perimenopause can show up in daily life.

Key findings

Women in the treatment group showed statistically significant improvements in vasomotor experiences — including reduced frequency and severity of hot flashes and night sweats — as well as measurable improvements in sleep quality and psychoemotional stability compared to the control group. These findings are consistent with what research has generally associated with hormonal changes during perimenopause, where fluctuating estrogen levels are linked to disruptions in thermoregulation, sleep, and mood.

Hormonal changes and perimenopause

Perimenopause is associated with declining and fluctuating estrogen and progesterone levels, which researchers have connected to a wide range of experiences — from temperature regulation changes to shifts in sleep patterns and emotional wellbeing. This study's design, which combined estrogen support with oral micronized progesterone, reflects broader interest in how hormonal changes during this life stage interact with these everyday experiences.

Safety and tolerability

The combination used in the study was well tolerated by participants, with no significant adverse safety signals reported within the study period. The researchers noted that oral micronized progesterone showed a favorable tolerability profile in the context of this trial.

You can view the full study here: https://jbiochemtech.com/article/transdermal-estra...

This article is for educational and general wellness purposes only. It is not medical advice and is not intended to diagnose, treat, cure, or prevent any disease. If you are noticing changes in your body or have questions about your health, please consult a knowledgeable healthcare provider.

Parlor Games products are not intended to treat, cure, prevent, or mitigate disease or other medical conditions. Our products are not the subject of the studies discussed herein, and we do not claim that our products will have the same effects as those discussed in these articles. This information is being provided for educational purposes only, and is not intended to replace the advice of a medical professional.